Teva Pharmaceutical Industries Ltd. (TEVA) on GreekSoup https://greeksoup.ai/stocks/us/teva/ Every dated entry in the public record on Teva Pharmaceutical Industries Ltd.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sun, 27 Sep 2026 00:00:00 +0000 Teva Pharmaceutical Industries Ltd.: Savage Brian (Interim Chief Legal Officer) sold 4,503 shares at $38.69 on 18 September 2026, $174,221https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-09-22:e13e17ce46Tue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Savage Brian (Interim Chief Legal Officer) sold 2,525 shares at $39.15 on 18 September 2026, $98,841https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-09-22:0c5b2985a3Tue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Savage Brian (Interim Chief Legal Officer) sold 314 shares at $38.70 on 18 September 2026, $12,153https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-09-22:1d92dbaa4bTue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Mignone Roberto (Director) sold 367,600 shares at $39.06 on 18 September 2026, $14.4 millionhttps://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-09-22:3197799806Tue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Form 144, Savage Brian plans to sell 7,028 shares worth $273,062 around 18 September 2026https://greeksoup.ai/stocks/us/teva/planned-sales/us:TEVA:planned-sale:2026-09-21:b5084de191Mon, 21 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Form 144, Bridger Management, LLC (1) plans to sell 367,600 shares worth $14.4 million around 18 September 2026https://greeksoup.ai/stocks/us/teva/planned-sales/us:TEVA:planned-sale:2026-09-18:13168bffa2Fri, 18 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 8-K: material agreement, new financial obligationhttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-09-16:6da108bbbcWed, 16 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: short interest 31,478,314 shares at the 15 September 2026 settlement, 27.35 days to coverhttps://greeksoup.ai/stocks/us/teva/short-interest/us:TEVA:short-interest:2026-09-15:b4b6de54a8Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-09-14:0e36ba479bMon, 14 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 25-NSEhttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-09-14:4a47249083Mon, 14 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-09-11:efe623074eFri, 11 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-09-03:1bad1c1621Thu, 03 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 8-K: change to security holders' rightshttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-09-03:c01f2ad152Thu, 03 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: short interest 37,614,253 shares at the 31 August 2026 settlement, 7.71 days to coverhttps://greeksoup.ai/stocks/us/teva/short-interest/us:TEVA:short-interest:2026-08-31:56d1c9cd6bMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Weiss Amir (Chief Accounting Officer) sold 6,945 shares at $37.61 on 21 August 2026, $261,224https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-08-25:4716ec1aa4Tue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Weiss Amir (Chief Accounting Officer) sold 2,500 shares at $37.63 on 21 August 2026, $94,077https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-08-25:4c2fb1efa3Tue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Satchi-Fainaro Ronit (Director) sold 415 shares at $37.25 on 21 August 2026, $15,459https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-08-25:b36c4067c8Tue, 25 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Lippman Evan (EVP, Business Development) sold 18,600 shares at $36.57 on 17 August 2026, $680,291https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-08-19:2787af1413Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Form 144, Lippman Evan plans to sell 18,600 shares worth $680,291 around 17 August 2026https://greeksoup.ai/stocks/us/teva/planned-sales/us:TEVA:planned-sale:2026-08-17:c786fdcae9Mon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: short interest 35,670,864 shares at the 14 August 2026 settlement, 6.63 days to coverhttps://greeksoup.ai/stocks/us/teva/short-interest/us:TEVA:short-interest:2026-08-14:ee10777f0fFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Zaks Tal Zvi (Director) sold 17 shares at $34.87 on 5 August 2026, $593https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-08-10:d7508635abMon, 10 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Jover Placid (See "Remarks") sold 12,827 shares at $34.88 on 3 August 2026, $447,351https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-08-05:54f37f1120Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Hughes Eric A (See "Remarks") sold 25,578 shares at $34.88 on 3 August 2026, $892,051https://greeksoup.ai/stocks/us/teva/insiders/us:TEVA:insider:2026-08-05:5edf74f0f4Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Form 144, Jover Placid plans to sell 12,827 shares worth $447,351 around 3 August 2026https://greeksoup.ai/stocks/us/teva/planned-sales/us:TEVA:planned-sale:2026-08-03:0961b4643eMon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: Form 144, Hughes Eric A plans to sell 25,578 shares worth $892,051 around 3 August 2026https://greeksoup.ai/stocks/us/teva/planned-sales/us:TEVA:planned-sale:2026-08-03:2693b19ab2Mon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: short interest 34,320,980 shares at the 31 July 2026 settlement, 5.74 days to coverhttps://greeksoup.ai/stocks/us/teva/short-interest/us:TEVA:short-interest:2026-07-31:c3c8dfb8e2Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. Q2 FY2026 results: revenue $4.1 billion, net income -$576 millionhttps://greeksoup.ai/stocks/us/teva/results/fy2026-q2/us:TEVA:result:2026-07-29:5e6ec5811cWed, 29 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-07-29:29108b6af0Wed, 29 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/teva/filings/us:TEVA:filing:2026-07-29:7253c5e3d2Wed, 29 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: short interest 32,741,011 shares at the 15 July 2026 settlement, 6.51 days to coverhttps://greeksoup.ai/stocks/us/teva/short-interest/us:TEVA:short-interest:2026-07-15:7c2e3312c8Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Teva Pharmaceutical Industries Ltd.: short interest 32,029,657 shares at the 30 June 2026 settlement, 5.10 days to coverhttps://greeksoup.ai/stocks/us/teva/short-interest/us:TEVA:short-interest:2026-06-30:7f9b2cad7aTue, 30 Jun 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>